Seattle sports, on tap daily

The Mets Cut Three, But One Bullpen Arm Just Saved Their Offseason

New York Mets logo on gradient background

Written by

in

New York Mets logo on gradient background
New York Mets logo on gradient background — Created by the Sports On Tap desk | Source : Sports On Tap (team logos property of their respective owners)

The New York Mets made some tough calls at the 5 PM ET tender deadline, opting to non-tender three players. Christopher Morel, Dylan Ross, and Hayden Senger are officially off the 40-man roster, marking a clear pivot for the club as they look towards 2027.

Shaking Up the Depth: Who’s Out and Why It Matters

Let’s be real, these non-tenders weren’t exactly shocks, but they show the Mets aren’t messing around. Christopher Morel, who they picked up off waivers from the Marlins, crushed it down in Triple-A Syracuse. You love to see that prospect fire. But at the big-league level in 2026, he just couldn’t translate it. He played in only 14 games, hitting a measly .200/.250/.333. His 31 wRC+ and -1.0 fWAR pretty much sealed his fate. It’s a tough business, and those numbers simply don’t cut it.

Then you have Dylan Ross and Hayden Senger. Ross wasn’t arbitration-eligible, got designated for assignment earlier in the week, and pitched just one scoreless major-league inning in September. Senger, also not arbitration-eligible, spent a month on the Mets’ 40-man roster after being there all season, playing in seven games with a .181/.221/.194 slash line, though he did manage to hit his first major-league home run. Every roster spot counts, especially when you’re trying to build a competitive team, and these moves free up space for whatever comes next.

Key Pieces Coming Back, Including a Bullpen Gem

It wasn’t all cuts, though. The Mets tendered contracts to a solid core, showing who they’re counting on. Francisco Alvarez, the catcher/designated hitter, showed flashes despite missing a month with a torn right meniscus. He put up a .233/.311/.399 line with a 99 wRC+ and 1.4 fWAR. Brett Baty’s versatility is clearly valued, as he bounced around defensively in a super-utility role, hitting .238/.311/.374 with a 92 wRC+ and 1.1 fWAR. That kind of defensive flexibility is gold.

On the pitching side, the Mets are betting on a couple of guys coming back strong from Tommy John surgery: Reed Garrett and Tylor Megill, both of whom should be ready for 2027 after their October and September 2025 surgeries, respectively. But the real standout here has to be Dedniel Núñez. This dude returned from his own Tommy John recovery in August 2026 and absolutely became one of their go-to relievers after the trade deadline. He threw 19.0 innings across 18 games with a 3.32 ERA, 3.73 FIP, and a nasty 0.89 WHIP, snagging a 0.1 fWAR. That’s a huge return on investment right there, giving the bullpen a much-needed boost heading into next year. Mark Vientos, who played 87 games, primarily at first base or DH, also got tendered despite a fractured hand in July that kept him out until the end of August. He finished with a .212/.258/.394 line, a 78 wRC+, and a -1.1 fWAR.

Finally, they locked down Cionel Pérez on a one-year deal. He joined the big-league club in late May after signing in May 2026, proving to be a multi-inning workhorse before a left forearm strain sidelined him until September. He posted a 4.76 ERA, 4.42 FIP, and 1.46 WHIP, with a -0.1 fWAR. That kind of adaptability from the bullpen is always a plus.

These moves, especially with the non-tenders and the commitment to guys like Núñez, mean the Mets are clearly focused on refining their roster and building for a more consistent 2027 season. They’re making space, betting on health, and banking on a few key guys to step up.

This article was created with AI assistance and published under Seattle On Tap’s editorial standards. See our Editorial Policy.

Originally reported by Amazin’ Avenue.

About the author

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *